Cello Health BioConsulting
  • menu
  • Home
  • About us
    • Why We’re Different
    • Our Team
    • Mission, Vision & Values
  • Capabilities
    • Common Client Dilemmas
    • Opportunity Assessments
    • Opportunity Search and Evaluation
    • Portfolio and Platform Strategy
    • Business Development & Partnering Strategy
    • Market Access Strategy
    • Early Stage Strategy
  • Our Insights
    • News
    • Presentations
    • Testimonials
    • Events
  • Careers
    • Current Opportunities
    • A Day in the Life
    • Our Culture

Our Insights

Antibiotics – The Next Big Thing, Again?

Antibiotics – The Next Big Thing, Again?

Infectious Disease | November 29, 2016
More +
Pricing and Paying for Progress: Disrupting the BioPharma Business Model

Pricing and Paying for Progress: Disrupting the BioPharma Business Model

Industry Presentation | November 18, 2016
Download PDF +
Pricing and Paying for Progress: Disrupting the BioPharma Business Model, LES Annual Meeting, October 25, 2016, Vancouver

Pricing and Paying for Progress: Disrupting the BioPharma Business Model, LES Annual Meeting, October 25, 2016, Vancouver

Industry Presentation | October 25, 2016
Download PDF +
The Future is Now: Dealing in a Transformed Healthcare Environment

The Future is Now: Dealing in a Transformed Healthcare Environment

Industry Presentation | September 13, 2016
Download PDF +
Supportive Neurology: Valuing Increased Function and Improved QoL in Treatment of Non-Core Symptoms of Neurological Disease

Supportive Neurology: Valuing Increased Function and Improved QoL in Treatment of Non-Core Symptoms of Neurological Disease

CNS | August 4, 2016
More +
New Biological Therapies for Asthma: Do the Benefits Justify the Cost?

New Biological Therapies for Asthma: Do the Benefits Justify the Cost?

Payer | Respiratory | May 17, 2016
More +
Connecting drug pricing to value: The industry’s greatest challenge

Connecting drug pricing to value: The industry’s greatest challenge

Industry Presentation | April 5, 2016
Download PDF +
After inflammation, fibrosis: Will biopharma follow nature’s lead?

After inflammation, fibrosis: Will biopharma follow nature’s lead?

Nash/Fibrosis | April 4, 2016
Download PDF +
Neurodegenerative disorders: Are we finally scaling the wall?

Neurodegenerative disorders: Are we finally scaling the wall?

CNS |
Download PDF +
Management of Diabetes: Beyond the Insulin and Incretin Pathways

Management of Diabetes: Beyond the Insulin and Incretin Pathways

CV & Metabolic |
Download PDF +
  2. ←
  3. 1
  4. 2
  5. 3
  6. 4
  7. 5
  8. 6
  9. 7
  10. 8
  11. 9
  12. →

Search

Elsewhere

Let’s work together

Contact us

  • Cello Health BioConsulting
  • 25-B Hanover Road
  • Suite 320
  • Florham Park, NJ
  • 07932
  • USA
  • +1 973 292 5001
  •  
  • Part of Cello Health plc

    Follow us

    Cello Health BioConsulting

    ©2021 Defined Health, now known as Cello Health BioConsulting | Privacy policy.

    View Presentation

    View Presentation

    Please fill the form to access the presentation.
    • This field is for validation purposes and should be left unchanged.

    We are using cookies to give you the best experience on our website.

    You can find out more about which cookies we are using or switch them off in settings.

    Defined Health, now known as Cello Health BioConsulting
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

    3rd Party Cookies

    This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

    Keeping this cookie enabled helps us to improve our website.

    Please enable Strictly Necessary Cookies first so that we can save your preferences!